EcoDrugPlus

Ribosomal Protein L37

Ensembl ID : ENSEEEG00000010180
Gene Symbol: RPL37
4 Cross references
428 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSEEEG00000012077
Gene Symbol: RPL38
4 Cross references
248 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSEEEG00000014481
Gene Symbol: RPL39
4 Cross references
542 Possible Orthologues:

Ribosomal Protein L5a

Ensembl ID : ENSEEEG00000011452
Gene Symbol: RPL5A
4 Cross references
447 Possible Orthologues:

Ribosomal Protein L5b

Ensembl ID : ENSEEEG00000005858
Gene Symbol: RPL5B
4 Cross references
448 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSEEEG00000015200
Gene Symbol: RPL6
2 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSEEEG00000023909
Gene Symbol: RPL7
4 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSEEEG00000014979
Gene Symbol: RPL7A
2 Cross references
372 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSEEEG00000023665
Gene Symbol: RPL8
4 Cross references
278 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSEEEG00000006842
Gene Symbol: RPL9
4 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSEEEG00000007178
Gene Symbol: RPS10
2 Cross references
384 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSEEEG00000003606
Gene Symbol: RPS11
4 Cross references
287 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).